PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System
Launched by KOCATEPE UNIVERSITY · Dec 30, 2015
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
Proliferative diabetic retinopathy (PDR) is a severe complication of diabetes mellitus characterized by new vessel formation in the retina and optic disc. Tight glycemic control and laser treatment in the early phases of the disease may slow the progression of PDR. Panretinal photocoagulation (PRP) is a laser-based treatment modality that destroys the outer retina layers and thereby improves the oxygen supply of the inner retina. During the following years, sequential improvements took place, including introduction of yellow, green, and diode lasers with various advantages of each wavelengt...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients (\>18 years) with type 1 or 2 diabetes and bilateral high-risk proliferative diabetic retinopathy (PDR)
- Exclusion Criteria:
- • Patients with a history of focal/grid photocoagulation, a history of orbital trauma, orbital infection or surgery, those with corneal or lens opacities, those with vitreous hemorrhage and non-compliant patients
About Kocatepe University
Kocatepe University is a distinguished academic institution located in Turkey, dedicated to advancing health sciences and medical research through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, Kocatepe University fosters an environment conducive to groundbreaking research aimed at improving patient outcomes. The university's commitment to ethical standards and rigorous scientific methodologies ensures the integrity and reliability of its clinical studies. By leveraging its state-of-the-art facilities and a team of experienced researchers, Kocatepe University strives to contribute significantly to the field of medicine and enhance the understanding of various health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Umit U Inan, M.D
Principal Investigator
Kocatepe University Medical School Department of Ophthalmology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials